Weighted-Average Shares Outstanding (Basic): The number of shares held by shareholders including insiders but not including a company's treasury shares, sourced from the company 10-K or 10-Q SEC reports.
Actuate Therapeutics, Inc. (ACTU) had Weighted-Average Shares Outstanding (Basic) of 21.02M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-22.23M |
|
-- |
|
-- |
|
$22.50M |
|
$-22.50M |
|
$0.27M |
|
$-22.23M |
|
$-22.23M |
|
$-22.23M |
|
$-22.23M |
|
$-22.23M |
|
$-22.23M |
|
$-22.50M |
|
$-22.50M |
|
|
Weighted-Average Shares Outstanding (Basic) |
21.02M |
21.02M |
|
$-1.06 |
|
$-1.06 |
|
| Balance Sheet Financials | |
$13.64M |
|
-- |
|
$0.39M |
|
$14.04M |
|
$5.71M |
|
-- |
|
$0.41M |
|
$6.11M |
|
$7.92M |
|
$7.92M |
|
$7.92M |
|
23.25M |
|
| Cash Flow Statement Financials | |
$-19.21M |
|
-- |
|
$23.72M |
|
$8.64M |
|
$13.16M |
|
$4.52M |
|
$6.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.39 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-19.21M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-280.51% |
|
-280.51% |
|
-158.36% |
|
-280.51% |
|
$0.34 |
|
$-0.91 |
|
$-0.91 |
|